Bausch Health Companies BHC
NYSE BHC
$6.44 -0.37 (-5.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bausch Health Companies (BHC) Non-Current Deffered Revenue (2009 - 2012)

Bausch Health Companies (BHC) posted Non-Current Deffered Revenue of $36.1 million for Q4 2012, down 1.63% sequentially from $36.7 million in Q3 2012, and down 5.31% YoY from $38.2 million in Q1 2012.

Bausch Health Companies (BHC) Non-Current Deffered Revenue (2009 - 2012) Analysis & Trends

Bausch Health Companies has reported Non-Current Deffered Revenue for 4 years, with the latest figure at $36.1 million in Q4 2012.

  • Quarterly Non-Current Deffered Revenue fell 5.31% year-over-year to $36.1 million in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $36.1 million (down 5.31% YoY) and the FY2012 annual result came in at $36.1 million, down 5.31% from the prior year.
  • Non-Current Deffered Revenue fell to $36.1 million in Q4 2012 per BHC's latest filing, from $36.7 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $69.2 million in Q4 2009 and troughed at $34.0 million in Q1 2012.
  • A 4-year average of $45.5 million and a median of $42.0 million in 2011 frame the typical range for Non-Current Deffered Revenue.
  • The sharpest annual moves came in 2011 and 2012: Non-Current Deffered Revenue retreated 28.5% in 2011, then declined 5.31% in 2012.
  • Over 4 years, Non-Current Deffered Revenue stood at $69.2 million in 2009, then retreated by 27.76% to $50.0 million in 2010, then fell by 23.73% to $38.2 million in 2011, then fell by 5.31% to $36.1 million in 2012.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $36.1 million, $36.7 million, and $37.9 million for Q4 2012, Q3 2012, and Q2 2012 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Bausch Health Companies 2.42 Bn 586.38 Mn 2.10 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2012 36.13 Mn
Sep 30, 2012 36.73 Mn
Jun 30, 2012 37.90 Mn
Mar 31, 2012 33.97 Mn
Dec 31, 2011 38.15 Mn
Sep 30, 2011 41.41 Mn
Jun 30, 2011 42.51 Mn
Mar 31, 2011 45.02 Mn
Dec 31, 2010 50.02 Mn
Sep 30, 2010 55.03 Mn
Jun 30, 2010 59.45 Mn
Dec 31, 2009 69.25 Mn